William J. Golden 
Mr. Golden has 35 years of experience as a financial executive of early stage companies and a venture capital investor. Since 1998, he has been a Co-Founder and Managing Director of Lancet Capital, an early stage biomedical venture capital fund that is licensed by the U.S. Small Business Administration and is affiliated with a number of leading Pittsburgh institutions including UPMC Health System, Highmark Blue Cross/Blue Shield, the University of Pittsburgh, Carnegie Mellon University and PNC Bank. Mr. Golden has a Masters in Business Administration degree from Harvard Business School and a Bachelor of Science degree in mechanical engineering (nuclear option) from the University of Notre Dame.

 
 
 
 
 

George L. Sing  
Mr. Sing has been a venture capital investor for over twenty years, including co-founding seed stage startups in healthcare and high technology. In addition to being a co-founder of Lancet Capital, he was also a co-founding senior partner of two other venture capital firms: Advanced Technology Ventures and Merrill Lynch Venture Capital, where he pioneered initial investments in European and Asian venture funds. Mr. Sing serves as a board director of Regeneron, a company he seeded at Merrill Lynch Venture Capital. Mr. Sing received a Master of Business Administration degree from Harvard Business School and a Bachelor of Engineering degree from Stevens Institute of Technology.